Clinical Trials Logo

Clinical Trial Summary

Kallmann syndrome (KS), also known as congenital hypogonadotropic hypogonadism (CHH), is a rare endocrine disorder that is characterized by failure to undergo puberty combined with infertility. KS/CHH patients face a number of psychosocial burdens related to delays in diagnosis, inadequate access to expert care, and lack of information about the condition. As such, there is some evidence to suggest that KS/CHH patients have unmet health needs. This study aims to identify the needs of patients and understand the issues that must be overcome to achieve improved health and quality of life.


Clinical Trial Description

This study aims to examine the experiences of patients diagnosed with Kallmann syndrome (KS)/congenital hypogonadotropic hypogonadism (CHH).

The study includes two parts:

- online survey (less than 30 minutes to complete)

- focus groups with KS/CHH patients

The aim of this project is to better understand what health needs are not presently being met for these patients and to identify targets for improving the care of patients diagnosed with KS/CHH ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01914172
Study type Observational
Source Centre Hospitalier Universitaire Vaudois
Contact
Status Completed
Phase N/A
Start date July 2013
Completion date September 27, 2017

See also
  Status Clinical Trial Phase
Completed NCT01403532 - Sequential Therapy for Hypogonadotropic Hypogonadism Phase 4
Recruiting NCT03687606 - Efficacy and Safety of Long Term Use of hCG or hCG Plus hMG in Males With Isolated Hypogonadotropic Hypogonadism (IHH) Phase 4
Recruiting NCT04463316 - GROWing Up With Rare GENEtic Syndromes
Terminated NCT03118479 - Effect of Varying Testosterone Levels on Insulin Sensitivity in Men With Idiopathic Hypogonadotropic Hypogonadism (IHH) Phase 1
Active, not recruiting NCT04733274 - Patient and Healthcare Professional Views on Genetic/Genomic Information and Testing
Recruiting NCT01601171 - Genetics of Reproductive Disorders (Including Kallmann Syndrome) and Cleft Lip and/or Palate
Completed NCT01438034 - Kisspeptin in the Evaluation of Delayed Puberty Phase 1
Recruiting NCT00914823 - Kisspeptin Administration in the Adult Phase 1
Completed NCT00392457 - Investigating the Regulation of Reproductive Hormones in Adult Men N/A
Recruiting NCT05971836 - The Molecular Basis of Inherited Reproductive Disorders
Completed NCT00494169 - Investigation of the Genetic Causes of Kallmann Syndrome and Reproductive Disorders
Completed NCT00493961 - Studying the Effects of 7 Days of Gonadotropin Releasing Hormone (GnRH) Treatment in Men With Hypogonadism Phase 1
Enrolling by invitation NCT00623116 - A Study to Characterize Epidemiology, Clinical and Genetic Features of Kallmann Syndrome in Finland N/A
Recruiting NCT02880280 - Human Menopausal Gonadotropin Combining With Human Chorionic Gonadotropin Treat Congenital Hypogonadotropic Hypogonadism Phase 4
Terminated NCT00064987 - Follicle Stimulating Hormone (FSH) to Improve Testicular Development in Men With Hypogonadism Phase 2
Completed NCT00392756 - Examination of Idiopathic Hypogonadotropic Hypogonadism (IHH)and Kallmann Syndrome (KS) Phase 1